Lexeo Therapeutics, Inc. (LXEO)
$4.92+0.82%Close
BUYRECOVERY · day 14
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $386M
- Avg volume
- 875.8K
- Beta
- 1.47
- P/E (TTM)
- -4.28
- Short % float
- 35.97%
- Days to cover
- 16.9
- SI change
- +4.3%
- 1W
- -1.20%
- 1M
- +5.58%
- 3M
- -3.72%
- YTD
- -48.80%
- vs SPY 1W
- -0.01%
- vs SPY 1M
- +2.26%
- vs SPY 3M
- -6.11%
- vs SPY YTD
- -60.56%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANABBUYAnaptysBio, Inc.RECOVERYQ 27$58.44+1.21%
- TENXSELLTenax Therapeutics, Inc.CRISISQ -6$1.85+5.71%
- TNXPBUYTonix Pharmaceuticals Holding Corp.RECOVERYQ -22$12.45-0.80%
- CELG-RIBUYBristol-Myers Squibb Company CeCRISISQ 8$0.10-16.67%
- BRNSBUYBarinthus Biotherapeutics plcRECOVERYQ -12$0.60-3.23%
- SIBNBUYSI-BONE, Inc.RECOVERYQ 5$19.47-2.45%
- AURABUYAura Biosciences, Inc.RECOVERYQ -3$7.90+1.28%
- AVBPSELLArriVent BioPharma, Inc. Common StockRECOVERYQ 21$28.26-2.95%
- AVLNBUYAvalyn Pharma Inc. Common StockQ 75$37.69-1.77%
- CLYMBUYClimb Bio, Inc.BULLQ 11$16.40-5.09%
- COAGBUYHemab Therapeutics Holdings, Inc. Common StockQ 70$46.67-5.07%
- DFTXSELLDefinium Therapeutics, Inc.RECOVERYQ 27$43.27-3.65%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-25.1%
REV YoY-
ROE-41.9%
EPS YoY-
ROA-34.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-4.28
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.79
P/FCF-
EV/EBITDA-3.51
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.90
ALTMAN Z-
CURR RATIO13.89
ND/EBITDA-
BETA1.47
